PM

Paolo Melloni

Director Director DIN 06983647
DIN 06983647 First appointment Oct 2014 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2014
Shareholding value Locked Premium profile

About Paolo Melloni

Data last updated:

Paolo Melloni has 11 years in corporate governance. Formerly with 1 company, such as Kedrion Biopharma India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06983647
Primary Designation Director
First Appointment 21 Oct 2014
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Managing Director21 Oct 20142013Under Liquidation

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kedrion Biopharma India Private Limited
Premium access

Shareholding and investment profile for Paolo Melloni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Paolo Melloni

Paolo Melloni has 11 years in corporate governance. Formerly with 1 company, such as Kedrion Biopharma India Private Limited. Engaged in General Business. Contributes to corporate operations.

Paolo Melloni is associated with 0 companies as a director.

Paolo Melloni has expertise in General Business.

Paolo Melloni has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available